FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/06/2026
Voltar para busca
Dado oficial do USPTO
A3P
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
A3P
ST13
US500000079397843Classe
5, 9, 10, 42, 44
Pedido
79397843
Registro
7979667
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
25/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 42, 44
Data de depósito
21/03/2024
Data de registro
14/10/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/10/2025
Última transação
25/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
SE
Examinador
SINGER, MELANIE ALYSSA
Unidade examinadora
M30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
A3P Biomedical AB
Representantes
Ronald E. Shapiro Shapiro and Silverstein PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical and veterinary preparations and articlesdiagnostic test reagents for medical purposes for prostate cancer testing; diagnostic preparations and material preparations in the nature of pharmaceuticals for medical purposes being for treatment of cancer; reagents for use in diagnostic tests for medical purposes; diagnostic testing materials for medical use in the nature of reagents for medical purposes; diagnostic test materials reagents for medical purposes for prostate cancer testing; diagnostic preparations for medical purposes; diagnostic agents for medical use
Classe 9
Downloadable software for calculating the risk of prostate cancer; downloadable computer programs for calculating the risk of prostate cancer; downloadable computer software for prostate cancer tests; downloadable application software for calculating the risk of prostate cancer; scientific research and laboratory apparatus for measuring proteins and genetics; educational apparatus and simulatorsmedical diagnostics training simulators in the field of prostate cancer; scientific laboratory research instruments for the detection of proteins and genetics for medical research and training purposes; and parts and fittings for all the aforesaid goods included in this classcomputer peripherals and parts thereof
Classe 10
Medical and veterinary apparatus and instrumentsprotein and genetics measurements instruments for diagnostic and treatment purposes; medical diagnosticexaminationmonitoring equipment for prostate cancer for medical treatment purposes; testing apparatus for medical purposes for prostate cancer detection; medical test instruments for diagnosis and treatment of prostate cancer; testing probes for medical diagnostic purposes; testing instruments for medical diagnostic purposes being for use in diagnosing prostate cancer; tools for medical diagnosis of prostate cancertools for calculation of prostate cancer risk; apparatus for carrying-out diagnostic tests for medical purposesultrasound diagnostic apparatus for diagnosing prostate cancer
Classe 42
IT integration services; computer software developmentprogramming and implementation for others; website hosting services; software as a service featuring computer software for calculating a prostate cancer risk score; rental of computer software for calculating cancer risk; providing temporary use of online non¬-downloadable computer software for calculating a prostate cancer risk score; application service providerfeaturing computer software programs for calculating a prostate cancer risk score; scientific and technology servicesscientific researchanalysistestingmedical and pharmacological research services in the field of prostate cancer; conducting research clinical trials for others in the field of prostate cancer; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website; medical research laboratory services in the field of prostate cancer; and adviceconsultancy and information relating to the aforesaidincluded in this classmedical research laboratory services
Classe 44
Human healthcare servicesdisease management programs; medical services; medical testing services; medical diagnostic services; medical diagnostic testing services for prostate cancer; providing online information services relating to medical and diagnostic testsnamely information regarding prostate cancer tests for diagnosis and treatment purposes; prostate cancer screening services; prostate cancer medical testing services; prostate cancer diagnostic medical testing services; medical testing services relating to prostate cancer; taking of blood for medical testing in the nature of phlebotomy services; services for the medical testing of blood; performing diagnosis of diseases; medical testing for diagnostic or treatment purposes; medical diagnostic servicesblood sampling and analysis; medical services for the diagnosis of conditions of the human body; medical analysis for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease in the nature of medical diagnostic services; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; providing medical information relating to medical results and diagnostic testsprostate cancer tests; providing medical diagnostic information relating to medical test results; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory analysis services for the analysis of samples and blood samples taken from patients for diagnostic and treatment purposes; rental of medical equipment for human healthcare; and adviceconsultancyinformation relating to the aforesaidincluded in this classmedical diagnostic consulting and information services
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/04/2026
FIMP
FINAL DISPOSITION PROCESSED
24/04/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/01/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/12/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/11/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
14/10/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/08/2025
PUBO
PUBLISHED FOR OPPOSITION
26/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/07/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
25/07/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/07/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
25/07/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/07/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
13/05/2025
GNFR
FINAL REFUSAL E-MAILED
13/05/2025
CNFR
FINAL REFUSAL WRITTEN
13/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/03/2025
DOCK
ASSIGNED TO EXAMINER
06/11/2024
RFNT
REFUSAL PROCESSED BY IB
26/10/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/10/2024
RFRR
REFUSAL PROCESSED BY MPU
07/10/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/09/2024
CNRT
NON-FINAL ACTION WRITTEN
29/09/2024
DOCK
ASSIGNED TO EXAMINER
29/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
21/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/06/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/06/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace A3P ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.